AI assistant
Dechra Pharmaceuticals PLC Director's Dealing 2022
4797_dirs_2022-07-25_afab7a4e-647f-4932-a275-e3931ccc1d3a.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 6697T
Dechra Pharmaceuticals PLC
25 July 2022
25 July 2022
Dechra Pharmaceuticals PLC
(the Company)
Notification of Transactions by Person Discharging Managerial Responsibilities
Dechra Pharmaceuticals PLC has been notified that Ishbel Macpherson, Non-Executive Director, participated in the Retail Offer as detailed in the Results of Placing announcement issued on 21 July 2022. She acquired 874 ordinary shares in the Company and these shares were admitted on 25 July 2022.
Following this acquisition, Ishbel Macpherson's beneficial interest in the Company is 6,722 shares (0.006% of the current issued share capital).
The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.
Notification of Dealing Form
| 1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
| a) | Name | Ishbel Macpherson | |
| 2. | Reason for the notification | ||
| a) | Position/status | Director | |
| b) | Initial notification/ amendment |
Initial Notification | |
| 3. | Details of the Issuer | ||
| a) | Name | Dechra Pharmaceuticals PLC | |
| b) | LEI code | 213800J4UVB5OWG8VX82 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument Identification code |
Ordinary Shares of 1 pence each ISIN: GB0009633180 |
|
| b) | Nature of the transaction | Purchase of Shares | |
| c) | Price(s) and volumes(s) | Price(s) £34.30 |
Volume(s) 874 |
| d) | Aggregated information - Aggregate volume - Price - Total |
874 £34.30 £29,978.20 |
|
| e) | Date of the transaction | 21 July 2022 | |
| f) | Place of the transaction | London Stock Exchange |
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBUGDRIUDDGDU